Skip to content
Sunday, October 4, 2026
Takeda’s Orzeyful secured Japan MHLW approval for narcolepsy type 1
FDA places clinical hold on REGENXBIO’s RGX-121 in MPS II trial
IceCure and Scovas agree for ProSense distribution in Netherlands
McKesson to buy Precision Medicine Group for $2.25bn

Insure Health

Newsletter
Random News
  • About US
  • Contact US
  • Disclaimer
  • Privacy Policy
  • Terms & Conditions
Takeda’s Orzeyful secured Japan MHLW approval for narcolepsy type 1
FDA places clinical hold on REGENXBIO’s RGX-121 in MPS II trial
IceCure and Scovas agree for ProSense distribution in Netherlands
McKesson to buy Precision Medicine Group for $2.25bn

Insure Health

Newsletter
Random News
  • About US
  • Contact US
  • Disclaimer
  • Privacy Policy
  • Terms & Conditions
Headlines

Takeda’s Orzeyful secured Japan MHLW approval for narcolepsy type 1

1 month ago11 hours ago

FDA places clinical hold on REGENXBIO’s RGX-121 in MPS II trial

1 month ago11 hours ago

IceCure and Scovas agree for ProSense distribution in Netherlands

1 month ago11 hours ago

McKesson to buy Precision Medicine Group for $2.25bn

1 month ago11 hours ago

Patient enrolment concludes in Senhwa’s Phase Ib trial of pidnarulex

1 month ago11 hours ago

Axoft launches Fleuron WISE polymer for advanced biological imaging

1 month ago11 hours ago

ViiV Healthcare’s Tivicay PD gains FDA approval for paediatric HIV therapy

1 month ago11 hours ago

HaemaLogiX doses first patient with KMCAR T-cell in KOALA trial

1 month ago11 hours ago

PENTAX broadens MAGENTIQ EYE partnership for global AI colonoscopy

1 month ago11 hours ago

FDA to review Kowa Pharmaceuticals’ NDA for glaucoma eye drop K-911

1 month ago11 hours ago
  • Home
  • Business & Clinical Development
  • Page 2

Business & Clinical Development

  • Business & Clinical Development
  • Health & Technology
  • Regulatory & Approvals

Monogram Health to pay $2.4M to settle Medicare Advantage upcoding allegations

Health Admin Hub1 month ago11 hours ago01 mins

Monogram, a home health company, overcharged Medicare through contracts with Cigna and Humana by inflating diagnostic codes, according to the Justice Department. Source link

Read Full News
  • Business & Clinical Development
  • Health & Technology
  • Regulatory & Approvals

No Surprises dispute resolution has generated $22B in extra costs, research finds

Health Admin Hub1 month ago11 hours ago01 mins

Accelerating dispute volumes and sky-high award amounts are inflating how much independent dispute resolution is costing the U.S., according to new Georgetown research. Patients could pay the price with higher premiums. Source link

Read Full News
  • Business & Clinical Development
  • Health & Technology
  • Regulatory & Approvals

Boston Scientific’s ordering, shipping disrupted in cyberattack

Health Admin Hub1 month ago11 hours ago01 mins

The attack affected global operations, and its full scope is still being determined, the medical device maker said in a securities filing. Source link

Read Full News
  • Business & Clinical Development
  • Health & Technology
  • Regulatory & Approvals

Suki launches AI dictation tool with EHR integration capabilities

Health Admin Hub1 month ago11 hours ago01 mins

Suki says its dictation tool, which can be integrated into Epic and Meditech, offers a highly accurate transcription that can be useful for clinicians working with complex medical jargon. Source link

Read Full News
  • Business & Clinical Development
  • Health & Technology
  • Regulatory & Approvals

Employers face ‘existential reckoning’ as health costs surge

Health Admin Hub1 month ago11 hours ago01 mins

Employers are expecting a median 9.2% increase in medical spending next year, according to a new survey. But they’ve underestimated actual cost growth for the past three years, so even that figure may be too optimistic. Source link

Read Full News
  • Business & Clinical Development
  • Health & Technology
  • Regulatory & Approvals

Sword Health to acquire Headspace

Health Admin Hub1 month ago11 hours ago01 mins

The all-cash deal is expected to close next month, after which Headspace’s wellness services will live under the same roof as Sword's virtual care platform, according to a filing with Massachusetts regulators. Source link

Read Full News
  • Business & Clinical Development
  • Health & Technology
  • Regulatory & Approvals

Most Americans want providers to disclose AI use, report says

Health Admin Hub1 month ago11 hours ago01 mins

Nearly half of adults don’t know whether AI has been used in their care, even as hospitals and doctors rapidly adopt the technology, according to a new survey from the Pew Research Center. Source link

Read Full News
  • Business & Clinical Development
  • Health & Technology
  • Regulatory & Approvals

Humana-owned Villages Health agrees to $542M settlement for overbilling Medicare

Health Admin Hub1 month ago11 hours ago01 mins

The Central Florida provider manufactured fake diagnosis codes for its Medicare Advantage patients from 2020 to 2024, the DOJ said. Humana bought The Villages Health last year. Source link

Read Full News
  • Business & Clinical Development
  • Health & Technology
  • Regulatory & Approvals

Specialty providers refute hefty Georgetown estimates of No Surprises costs

Health Admin Hub1 month ago11 hours ago01 mins

Researchers estimate that independent dispute resolution has created $22 billion in unnecessary spending. But that estimate is flawed, argue associations representing anesthesiologists, radiologists and ER doctors. Source link

Read Full News
  • Business & Clinical Development
  • Health & Technology
  • Regulatory & Approvals

Physicians want compensation boost from AI productivity gains: survey

Health Admin Hub1 month ago11 hours ago01 mins

More than 65% of physicians use AI daily or weekly for clinical or administrative work — and some believe they should be paid more if the tech increases their efficiency, according to a Doximity report. Source link

Read Full News
  • 1
  • 2

Recent Posts

  • Takeda’s Orzeyful secured Japan MHLW approval for narcolepsy type 1
  • FDA places clinical hold on REGENXBIO’s RGX-121 in MPS II trial
  • IceCure and Scovas agree for ProSense distribution in Netherlands
  • McKesson to buy Precision Medicine Group for $2.25bn
  • Patient enrolment concludes in Senhwa’s Phase Ib trial of pidnarulex

Pages Lists

  • About US
  • Contact US
  • Disclaimer
  • Privacy Policy
  • Terms & Conditions

Categories Lists

  • Business & Clinical Development
  • Health & Technology
  • Regulatory & Approvals
Newsmatic - News WordPress Theme 2026. Powered By BlazeThemes.